UB Paderborn / Katalog / Suche / in CDI

A Hyper-Glycosylation of HBV Surface Antigen Correlates with HBsAg-Negativity at Immunosuppression-Driven HBV Reactivation in Vivo and Hinders HBsAg Recognition in Vitro

Viruses, 2020-02, Vol.12 (2), p.251

2020

Volltextzugriff (PDF)

Hepatitis B virus reactivation sustained by a hepatitis B virus surface antigen immune-escape mutant isolate in a patient who was hepatitis B core antibody positive during treatment with sofosbuvir and velpatasvir for hepatitis C virus infection: a case report

Journal of medical case reports, 2019-09, Vol.13 (1), p.299-299, Article 299

2019

Volltextzugriff (PDF)

NS5A Gene Analysis by Next Generation Sequencing in HCV Nosocomial Transmission Clusters of HCV Genotype 1b Infected Patients

Cells (Basel, Switzerland), 2019-07, Vol.8 (7), p.666

2019

Volltextzugriff (PDF)

Multiclass HCV resistance to direct‐acting antiviral failure in real‐life patients advocates for tailored second‐line therapies

Liver international, 2017-04, Vol.37 (4), p.514-528

2017

Volltextzugriff (PDF)

Multiple Hepatitis B Virus (HBV) Quasispecies and Immune-Escape Mutations Are Present in HBV Surface Antigen and Reverse Transcriptase of Patients With Acute Hepatitis B

The Journal of infectious diseases, 2016-06, Vol.213 (12), p.1897-1905

2016

Volltextzugriff (PDF)

Hepatitis C virus gene sequencing as a tool for precise genotyping in the era of new direct antiviral agents

Hepatology (Baltimore, Md.), 2016-03, Vol.63 (3), p.1058-1059

2016

Volltextzugriff (PDF)

Reactivation of Hepatitis B Virus With Immune-Escape Mutations After Ocrelizumab Treatment for Multiple Sclerosis

Open forum infectious diseases, 2019-01, Vol.6 (1), p.ofy356

2019

Volltextzugriff (PDF)

Establishment of a Seronegative Occult Infection With an Active Hepatitis B Virus Reservoir Enriched of Vaccine Escape Mutations in a Vaccinated Infant After Liver Transplantation

The Journal of infectious diseases, 2019-11, Vol.220 (12), p.1935-1939

2019

Volltextzugriff (PDF)

Optimal cure rate by personalized HCV regimens in real-life: a proof-of-concept study

Journal of antimicrobial chemotherapy, 2017-12, Vol.72 (12), p.3420-3424

2017

Volltextzugriff (PDF)

Prevalence of Single and Multiple Natural NS3, NS5A and NS5B Resistance-Associated Substitutions in Hepatitis C Virus Genotypes 1-4 in Italy

Scientific reports, 2018-06, Vol.8 (1), p.8988-11, Article 8988

2018

Volltextzugriff (PDF)

Prevalence of resistance-associated substitutions and retreatment of patients failing a glecaprevir/pibrentasvir regimen

Journal of antimicrobial chemotherapy, 2020-11, Vol.75 (11), p.3349-3358

2020

Volltextzugriff (PDF)

Frequent NS5A and multiclass resistance in almost all HCV genotypes at DAA failures: What are the chances for second-line regimens?

Journal of hepatology, 2018-03, Vol.68 (3), p.597-600

2018

Volltextzugriff (PDF)

Implications of hepatitis C virus subtype 1a migration patterns for virus genetic sequencing policies in Italy

BMC evolutionary biology, 2017-03, Vol.17 (1), p.70

2017

Volltextzugriff (PDF)

HCV very late relapse following an atypical viral kinetics in a HIV patient treated for hepatitis C with direct-acting antivirals

Infection, 2018-10, Vol.46 (5), p.717-720

2018

Volltextzugriff (PDF)

Resistance and phylogenetic analysis in HCV-2c infected patients within the Italian network VIRONET-C

Journal of hepatology, 2020-08, Vol.73, p.S336-S338

2020

Volltextzugriff (PDF)

THU403 - Resistance and phylogenetic analysis in HCV-2c infected patients within the Italian network VIRONET-C

Journal of hepatology, 2020-08, Vol.73, p.S336-S338

2020

Volltextzugriff (PDF)

Evidence of Spontaneous Post-transplant HCV Eradication in Two Failed DAA Treatments Awaiting Liver Transplantation

Digestive diseases and sciences, 2017-08, Vol.62 (8), p.2193-2195

2017

Volltextzugriff (PDF)

SAT-190-Specific genetic elements in HBsAg C-terminus profoundly affect HBsAg levels in vivo, hamper HBsAg secretion in vitro and alter HBsAg structural stability in HBeAg-negative chronic HBV genotype D infection

Journal of hepatology, 2019-04, Vol.70 (1), p.e713-e714

2019

Volltextzugriff (PDF)

THU-117-Evaluation of risk factors associated with failure to a first-line NS5A-containing regimen in HCV-infected patients naive to direct acting antivirals: Particular focus on natural resistance

Journal of hepatology, 2019-04, Vol.70 (1), p.e209-e210

2019

Volltextzugriff (PDF)

THU-133-Resistance-guided retreatment of HCV infected patients with a previous failure to an NS5A inhibitor-containing regimen: Italian real life experience

Journal of hepatology, 2019-04, Vol.70 (1), p.e218-e219

2019

Volltextzugriff (PDF)

Consequences of inaccurate hepatitis C virus genotyping on the costs of prescription of direct antiviral agents in an Italian district

ClinicoEconomics and outcomes research, 2016-01, Vol.8, p.467-473

2016

Volltextzugriff (PDF)

Menü

Weitere Dienste

Einstellungen

A Hyper-Glycosylation of HBV Surface Antigen Correlates with HBsAg-Negativity at Immunosuppression-Driven HBV Reactivation in Vivo and Hinders HBsAg Recognition in Vitro

Hepatitis B virus reactivation sustained by a hepatitis B virus surface antigen immune-escape mutant isolate in a patient who was hepatitis B core antibody positive during treatment with sofosbuvir and velpatasvir for hepatitis C virus infection: a case report

NS5A Gene Analysis by Next Generation Sequencing in HCV Nosocomial Transmission Clusters of HCV Genotype 1b Infected Patients

Hepatitis B surface antigen genetic elements critical for immune escape correlate with hepatitis B virus reactivation upon immunosuppression

Multiclass HCV resistance to direct‐acting antiviral failure in real‐life patients advocates for tailored second‐line therapies

Multiple Hepatitis B Virus (HBV) Quasispecies and Immune-Escape Mutations Are Present in HBV Surface Antigen and Reverse Transcriptase of Patients With Acute Hepatitis B

Hepatitis C virus gene sequencing as a tool for precise genotyping in the era of new direct antiviral agents

Reactivation of Hepatitis B Virus With Immune-Escape Mutations After Ocrelizumab Treatment for Multiple Sclerosis

Establishment of a Seronegative Occult Infection With an Active Hepatitis B Virus Reservoir Enriched of Vaccine Escape Mutations in a Vaccinated Infant After Liver Transplantation

Optimal cure rate by personalized HCV regimens in real-life: a proof-of-concept study

Prevalence of Single and Multiple Natural NS3, NS5A and NS5B Resistance-Associated Substitutions in Hepatitis C Virus Genotypes 1-4 in Italy

Prevalence of resistance-associated substitutions and retreatment of patients failing a glecaprevir/pibrentasvir regimen

Frequent NS5A and multiclass resistance in almost all HCV genotypes at DAA failures: What are the chances for second-line regimens?

Implications of hepatitis C virus subtype 1a migration patterns for virus genetic sequencing policies in Italy

HCV very late relapse following an atypical viral kinetics in a HIV patient treated for hepatitis C with direct-acting antivirals

Resistance and phylogenetic analysis in HCV-2c infected patients within the Italian network VIRONET-C

THU403 - Resistance and phylogenetic analysis in HCV-2c infected patients within the Italian network VIRONET-C

Evidence of Spontaneous Post-transplant HCV Eradication in Two Failed DAA Treatments Awaiting Liver Transplantation

SAT-159-Genetic determinants in critical domains of NS5A are associated with genotype 1b HCV-induced hepatocellular carcinoma

SAT-190-Specific genetic elements in HBsAg C-terminus profoundly affect HBsAg levels in vivo, hamper HBsAg secretion in vitro and alter HBsAg structural stability in HBeAg-negative chronic HBV genotype D infection

THU-117-Evaluation of risk factors associated with failure to a first-line NS5A-containing regimen in HCV-infected patients naive to direct acting antivirals: Particular focus on natural resistance

THU-133-Resistance-guided retreatment of HCV infected patients with a previous failure to an NS5A inhibitor-containing regimen: Italian real life experience

Specific mutations in the C-terminus domain of HBV surface antigen significantly correlate with low level of serum HBV-DNA in patients with chronic HBV infection

Consequences of inaccurate hepatitis C virus genotyping on the costs of prescription of direct antiviral agents in an Italian district

Hepatitis C virus RNA levels at week-2 of telaprevir/boceprevir administration are predictive of virological outcome

Suchergebnisse filtern